Strategy
MSTR
MARA Holdings
MARA
Alphabet-C
GOOG
Alphabet-A
GOOGL
NVIDIA
NVDA
US Stock MarketDetailed Quotes
HOWL Werewolf Therapeutics
- 1.120
- -0.020-1.75%
Trading Mar 4 12:39 ET
49.91MMarket Cap-0.74P/E (TTM)
1.129High1.030Low131.93KVolume1.090Open1.140Pre Close144.51KTurnover0.51%Turnover RatioLossP/E (Static)44.56MShares6.89052wk High0.56P/B29.25MFloat Cap1.03052wk Low--Dividend TTM26.12MShs Float23.990Historical High--Div YieldTTM8.72%Amplitude1.030Historical Low1.095Avg Price1Lot Size
About Werewolf Therapeutics Company
Werewolf Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of therapeutics engineered to stimulate the body’s immune system for the treatment of cancer. The firm offers Predator Technology which focuses on immune targeting and activation. The company was founded by Daniel J. Hicklin, Patrick A. Baeuerle, and Luke B. Evnin on October 19, 2017 and is headquartered in Watertown, MA.
Company Profile
SymbolHOWL
Company NameWerewolf Therapeutics
Listing DateApr 30, 2021
Issue Price16.00
Founded2017
CEODr. Daniel J. Hicklin,, PhD
MarketNASDAQ
Employees47
Fiscal Year Ends12-31
Address200 Talcott Avenue,2nd floor
CityWatertown
ProvinceMassachusetts
CountryUnited States of America
Zip Code02472
Phone1-617-952-0555
Websitehttp://www.werewolftx.com
Company Executives
- Name
- Position
- Salary
- Dr. Daniel J. Hicklin,, PhD
- Director, President and Chief Executive Officer
- 1.37M
- Dr. Chulani Karunatilake, PhD
- Chief Technology Officer
- --
- Ellen Lubman, M.B.A.
- Chief Business Officer
- --
- Timothy W. Trost
- Chief Financial Officer, Principal Accounting Officer and Treasurer
- 815.59K
- Dr. Randi Isaacs, M.D.
- Chief Medical Officer
- 855.77K
- Dr. Luke B. Evnin,PhD
- Chairman of the Board
- 104.03K
- Dr. Briggs W. Morrison, M.D.
- Director
- 62.32K
- Dr. Anil K. Singhal, PhD
- Director
- --
- Dr. Michael B. Atkins, M.D.
- Director
- --
- Dr. Derek DiRocco, PhD
- Independent Director
- 72.53K
- Michael Sherman
- Independent Director
- 78.66K
- Dr. Meeta Chatterjee, PhD
- Independent Director
- 65.36K
- Dr. Alon Lazarus, PhD
- Independent Director
- 78.53K
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.